Eton Pharmaceuticals
(NASDAQ) ETON
Eton Pharmaceuticals Financials at a Glance
Market Cap
$977.91M
Revenue (TTM)
$86.93M
Net Income (TTM)
-$1.48M
EPS (TTM)
-$0.07
P/E Ratio
-502.82
Dividend
$0.00
Beta (Volatility)
0.79 (Low)
Dividend
$0.00
Beta (Volatility)
0.79 (Low)
Price
$35.64
Volume
1,003,515.147
Open
$34.93
Price
$35.64
Volume
1,003,515.147
Open
$34.93
Previous Close
$35.70
Daily Range
$34.65 - $35.99
52-Week Range
$13.51 - $35.99
Estimated Earnings Date
Aug 6, 2026
Dividend
$0.00
Beta (Volatility)
0.79 (Low)
Price
$35.64
Volume
1,003,515.147
Open
$34.93
Previous Close
$35.70
Daily Range
$34.65 - $35.99
52-Week Range
$13.51 - $35.99
Estimated Earnings Date
Aug 6, 2026
ETON News
ETON: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Eton Pharmaceuticals
Industry
Pharmaceuticals
Sector
Health CareEmployees
44
CEO
Sean E. Brynjelsen, MBA
Website
www.etonpharma.comHeadquarters
Deer Park, IL 60010-7278, US
ETON Financials
Key Financial Metrics (TTM)
Gross Margin
54.77%
Operating Margin
2.35%
Net Income Margin
-1.70%
Return on Equity
-5.68%
Return on Capital
0.13%
Return on Assets
-1.51%
Earnings Yield
-0.20%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$977.91M
Shares Outstanding
27.39M
Volume
1.00M
Avg. Volume
414.21K
Financials (TTM)
Gross Profit
$47.61M
Operating Income
$2.04M
EBITDA
$5.45M
Operating Cash Flow
$15.84M
Capital Expenditure
-$408.00K
Free Cash Flow
$15.43M
Cash & ST Invst.
$19.66M
Total Debt
$12.25M
Eton Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$24.27M
+40.4%
Gross Profit
$14.74M
+49.4%
Gross Margin
60.72%
N/A
Market Cap
$977.91M
N/A
Market Cap/Employee
$22.23M
N/A
Employees
44
N/A
Net Income
$1.55M
+198.9%
EBITDA
$1.87M
+175.1%
Quarterly Fundamentals
Total Cash
$19.66M
+12.9%
Total Debt
$12.25M
-59.4%
Accounts Receivable
$13.41M
-18.2%
Inventory
$14.47M
+6.2%
Long Term Debt
$440.00K
-98.5%
Short Term Debt
$11.81M
+15235.1%
Return on Assets
-1.51%
N/A
Return on Invested Capital
3.81%
N/A
Free Cash Flow
$7.33M
+250.7%
Operating Cash Flow
$7.41M
+254.3%